KEITH CRANDELL
CIK 1219039 · last filed 2026-02-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$611.88M
Companies
20
Total Filings
73
Lifetime Open-Market Net
$395.91M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TWST | Director | 103,618 | $76.17 | $7.89M | -$11.52M | 13 | 2026-02-09 |
| NMRA | 10%+ Owner | 6,046,907 | $1.78 | $10.76M | $258.64M | 5 | 2025-10-29 |
| LYEL | 10%+ Owner | 910,317 | $13.50 | $12.29M | $0 | 1 | 2025-07-29 |
| MASS | Director | 5,750,336 | $8.27 | $47.56M | $6.00M | 7 | 2025-06-13 |
| SANA | 10%+ Owner | 12,446,022 | $2.68 | $33.36M | $40.00M | 1 | 2024-02-12 |
| QTRX | Director | 308,483 | $3.10 | $956.3K | $3.99M | 22 | 2023-04-04 |
| VIR | 10%+ Owner | 7,563,619 | $8.61 | $65.12M | $0 | 1 | 2022-09-07 |
| DA32 Life Science Tech Acquisition Corp. (DALS) Delisted | Director | 2,250,000 | $10.32 | $23.22M | $16.00M | 2 | 2021-08-09 |
| ADESTO TECHNOLOGIES Corp (IOTS) Delisted | Director | 1,177,937 | — | — | $2.00M | 6 | 2019-06-06 |
| SYRS | 10%+ Owner | 4,350,871 | $0.00 | $1.7K | -$14.59M | 2 | 2019-03-14 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | 10%+ Owner | 2,900,575 | — | — | $70.39M | 2 | 2019-02-26 |
| PULM | 3,436,456 | $1.40 | $4.81M | $0 | 1 | 2018-04-05 | |
| Q32 Bio Inc. (FIXX) Delisted | 10%+ Owner | 6,068,695 | $16.82 | $102.10M | $0 | 1 | 2018-04-04 |
| DNLI | 10%+ Owner | 11,068,749 | $21.66 | $239.75M | $0 | 1 | 2017-12-12 |
| XTERA COMMUNICATIONS, INC. (XCOM) Delisted | 10%+ Owner | — | — | — | $0 | 2 | 2016-10-13 |
| PI | 10%+ Owner | 1,388,049 | $132.77 | $184.29M | $0 | 1 | 2016-07-26 |
| Sage Therapeutics, Inc. (SAGE) Delisted | 10%+ Owner | 3,187,044 | $8.68 | $27.66M | $0 | 1 | 2015-01-16 |
| FATE | 10%+ Owner | 2,473,188 | $2.06 | $5.09M | $25.00M | 1 | 2013-10-07 |
| KYTHERA BIOPHARMACEUTICALS INC (KYTH) Delisted | 10%+ Owner | 1,897,474 | — | — | $0 | 1 | 2012-10-16 |
| CELEBRATE EXPRESS, INC. (BDAY) Delisted | Director | — | — | — | $0 | 1 | 2007-10-23 |
Recent Filings · Page 6 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-14 | SYRS | Sell (S) | −1,005,018 | -$7.87M | EDGAR |
| 2019-03-11 | SYRS | Sell (S) | −987,498 | -$6.71M | EDGAR |
| 2019-02-26 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Buy (P) | +15,160,600 | $37.90M | EDGAR |
| 2019-02-26 | Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Buy (P) | +12,994,800 | $32.49M | EDGAR |
| 2019-01-04 | QTRX | Grant (A) | +2,270 | $0 | EDGAR |
| 2018-11-06 | TWST | Mixed | +3,361,568 | $1.05M | EDGAR |
| 2018-08-09 | QTRX | Grant (A) | +2,270 | $0 | EDGAR |
| 2018-07-31 | ADESTO TECHNOLOGIES Corp (IOTS) Delisted | Grant (A) | +3,243 | $0 | EDGAR |
| 2018-04-05 | PULM | Buy (P) | +8,050,000 | $0 | EDGAR |
| 2018-04-04 | Q32 Bio Inc. (FIXX) Delisted | Conv (C) | +42,480,865 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.